Terms: = Prostate cancer AND TIMP1, CLGI, EPA, EPO, HCI, TIMP, TIMP-1 AND Treatment
83 results:
1. Tetracaine downregulates matrix metalloproteinase activity and inhibits invasiveness of strongly metastatic MDA-MB-231 human breast cancer cells.
Keleş D; Sipahi M; İnanç-Sürer Ş; Djamgoz MB; Oktay G
Chem Biol Interact; 2023 Nov; 385():110730. PubMed ID: 37806380
[TBL] [Abstract] [Full Text] [Related]
2. The Potential of DHA as cancer Therapy Strategies: A Narrative Review of In Vitro Cytotoxicity Trials.
de Freitas Rodrigues J; Philippsen HK; Dolabela MF; Nagamachi CY; Pieczarka JC
Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111226
[TBL] [Abstract] [Full Text] [Related]
3. A Novel L-Phenylalanine Dipeptide Inhibits the Growth and Metastasis of prostate cancer Cells via Targeting DUSP1 and TNFSF9.
Li L; Yang M; Yu J; Cheng S; Ahmad M; Wu C; Wan X; Xu B; Ben-David Y; Luo H
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142828
[TBL] [Abstract] [Full Text] [Related]
4. The Effect of Suppression Taurine on Relocation and Epithelial-Mesenchymal Transition in Mankind Lung cancer Cells.
Deng Y; Li H; Tang Y
J Healthc Eng; 2021; 2021():6656080. PubMed ID: 33936579
[TBL] [Abstract] [Full Text] [Related]
5. Safety of Eicosapentaenoic Acid in cancer treatment: Effect on cancer Cells and Chemotherapy in Vitro.
Aktaş S; Ercetin P; Altun Z; Kantar M; Olgun N
Nutr Cancer; 2021; 73(4):568-571. PubMed ID: 33678115
[TBL] [Abstract] [Full Text] [Related]
6. Angiokines Associated with Targeted Therapy Outcomes in Patients with Non-Clear Cell Renal Cell Carcinoma.
Armstrong AJ; Nixon AB; Carmack A; Yang Q; Eisen T; Stadler WM; Jones RJ; Garcia JA; Vaishampayan UN; Picus J; Hawkins RE; Hainsworth JD; Kollmannsberger CK; Logan TF; Puzanov I; Pickering LM; Ryan CW; Protheroe A; George DJ; Halabi S
Clin Cancer Res; 2021 Jun; 27(12):3317-3328. PubMed ID: 33593885
[TBL] [Abstract] [Full Text] [Related]
7. Multi-institutional Outcomes and Associations After Excision and Primary Anastomosis for Radiotherapy-associated Bulbomembranous Urethral Stenoses Following prostate cancer treatment.
Voelzke BB; Leddy LS; Myers JB; Breyer BN; Alsikafi NF; Broghammer JA; Elliott SP; Vanni AJ; Erickson BA; Buckley JC; Zhao LC; Wright T; Rourke KF;
Urology; 2021 Jun; 152():117-122. PubMed ID: 33556448
[TBL] [Abstract] [Full Text] [Related]
8. Senescence Reprogramming by timp1 Deficiency Promotes prostate cancer Metastasis.
Guccini I; Revandkar A; D'Ambrosio M; Colucci M; Pasquini E; Mosole S; Troiani M; Brina D; Sheibani-Tezerji R; Elia AR; Rinaldi A; Pernigoni N; Rüschoff JH; Dettwiler S; De Marzo AM; Antonarakis ES; Borrelli C; Moor AE; Garcia-Escudero R; Alajati A; Attanasio G; Losa M; Moch H; Wild P; Egger G; Alimonti A
Cancer Cell; 2021 Jan; 39(1):68-82.e9. PubMed ID: 33186519
[TBL] [Abstract] [Full Text] [Related]
9. ESTAT3 Inhibitor AG-490 Inhibits the Growth of prostate cancer by miR-503-5p Both In Vivo and In Vitro.
Tan G; Jiang L; Li G; Bai K
Technol Cancer Res Treat; 2020; 19():1533033820948062. PubMed ID: 33063634
[TBL] [Abstract] [Full Text] [Related]
10. Hypoxia Promotes prostate cancer Aggressiveness by Upregulating EMT-Activator Zeb1 and SK3 Channel Expression.
Bery F; Figiel S; Kouba S; Fontaine D; Guéguinou M; Potier-Cartereau M; Vandier C; Guibon R; Bruyère F; Fromont G; Mahéo K
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32640738
[TBL] [Abstract] [Full Text] [Related]
11. Resveratrol inhibits the tumor migration and invasion by upregulating TET1 and reducing timp2/3 methylation in prostate carcinoma cells.
Wang K; Chen Z; Shi J; Feng Y; Yu M; Sun Y; Zhuang Q; Liang B; Luo G; Xu X; Fan M
Prostate; 2020 Sep; 80(12):977-985. PubMed ID: 32542727
[TBL] [Abstract] [Full Text] [Related]
12. Chemokine releasing particle implants for trapping circulating prostate cancer cells.
Huang Y; Hakamivala A; Li S; Nair A; Saxena R; Hsieh JT; Tang L
Sci Rep; 2020 Mar; 10(1):4433. PubMed ID: 32157115
[TBL] [Abstract] [Full Text] [Related]
13. Green tea-induced epigenetic reactivation of tissue inhibitor of matrix metalloproteinase-3 suppresses prostate cancer progression through histone-modifying enzymes.
Deb G; Shankar E; Thakur VS; Ponsky LE; Bodner DR; Fu P; Gupta S
Mol Carcinog; 2019 Jul; 58(7):1194-1207. PubMed ID: 30854739
[TBL] [Abstract] [Full Text] [Related]
14. Attenuation of Metabolic Syndrome by epa/DHA Ethyl Esters in Testosterone-Deficient Obese Rats.
Bhandarkar NS; Kumar SA; Martin J; Brown L; Panchal SK
Mar Drugs; 2018 May; 16(6):. PubMed ID: 29794984
[TBL] [Abstract] [Full Text] [Related]
15. Anticancer mechanism of Sinapic acid in PC-3 and LNCaP human prostate cancer cell lines.
Eroğlu C; Avcı E; Vural H; Kurar E
Gene; 2018 Sep; 671():127-134. PubMed ID: 29792952
[TBL] [Abstract] [Full Text] [Related]
16. Identification of Novel Response and Predictive Biomarkers to Hsp90 Inhibitors Through Proteomic Profiling of Patient-derived prostate Tumor Explants.
Nguyen EV; Centenera MM; Moldovan M; Das R; Irani S; Vincent AD; Chan H; Horvath LG; Lynn DJ; Daly RJ; Butler LM
Mol Cell Proteomics; 2018 Aug; 17(8):1470-1486. PubMed ID: 29632047
[TBL] [Abstract] [Full Text] [Related]
17. Effects of concentrated long-chain omega-3 polyunsaturated fatty acid supplementation before radical prostatectomy on prostate cancer proliferation, inflammation, and quality of life: study protocol for a phase IIb, randomized, double-blind, placebo-controlled trial.
Guertin MH; Robitaille K; Pelletier JF; Duchesne T; Julien P; Savard J; Bairati I; Fradet V
BMC Cancer; 2018 Jan; 18(1):64. PubMed ID: 29321047
[TBL] [Abstract] [Full Text] [Related]
18. MicroRNA-124a inhibits cell proliferation and migration in liver cancer by regulating interleukin-11.
Yu L; Wang S; Lin X; Lu Y; Gu P
Mol Med Rep; 2018 Mar; 17(3):3972-3978. PubMed ID: 29286137
[TBL] [Abstract] [Full Text] [Related]
19. Aspirin Inhibits IKK-β-mediated prostate cancer Cell Invasion by Targeting Matrix Metalloproteinase-9 and Urokinase-Type Plasminogen Activator.
Shi C; Zhang N; Feng Y; Cao J; Chen X; Liu B
Cell Physiol Biochem; 2017; 41(4):1313-1324. PubMed ID: 28278500
[TBL] [Abstract] [Full Text] [Related]
20. Effects of ω-3 Fatty Acids and Catechins on Fatty Acid Synthase in the prostate: A Randomized Controlled Trial.
Zhang Z; Garzotto M; Beer TM; Thuillier P; Lieberman S; Mori M; Stoller WA; Farris PE; Shannon J
Nutr Cancer; 2016; 68(8):1309-1319. PubMed ID: 27646578
[TBL] [Abstract] [Full Text] [Related]
[Next]
